Stock 6960 FUKUDA DENSHI CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fukuda Denshi Co., Ltd.

Equities

6960

JP3806000000

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-02 am EDT 		5-day change 1st Jan Change
6,680 JPY +1.67% Intraday chart for Fukuda Denshi Co., Ltd. +6.88% -9.36%
Feb. 21 Fukuda Denshi Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Feb. 21 Fukuda Denshi Co., Ltd. Provides Special Dividend Guidance for the Year Ending March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 118,998 114,439 126,994 127,156 118,107 129,010
Enterprise Value (EV) 1 75,199 71,497 81,835 73,104 57,375 64,222
P/E ratio 12.8 x 11.9 x 13.3 x 8.64 x 7.28 x 7.47 x
Yield 1.41% 1.53% 1.37% 1.72% 2.05% 2.58%
Capitalization / Revenue 0.92 x 0.88 x 0.95 x 0.87 x 0.89 x 0.96 x
EV / Revenue 0.58 x 0.55 x 0.61 x 0.5 x 0.43 x 0.48 x
EV / EBITDA 3.8 x 3.49 x 3.84 x 2.59 x 1.81 x 1.92 x
EV / FCF 7.65 x 10.7 x 14.7 x 7.31 x 9.61 x 8.64 x
FCF Yield 13.1% 9.38% 6.8% 13.7% 10.4% 11.6%
Price to Book 1.05 x 0.96 x 1.02 x 0.92 x 0.79 x 0.79 x
Nbr of stocks (in thousands) 30,434 30,436 30,237 30,239 30,245 30,249
Reference price 2 3,910 3,760 4,200 4,205 3,905 4,265
Announcement Date 6/28/18 6/27/19 6/26/20 6/29/21 6/29/22 6/29/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 128,883 129,775 133,393 146,756 132,098 134,648
EBITDA 1 19,794 20,501 21,296 28,172 31,726 33,463
EBIT 1 12,335 12,645 13,284 19,812 22,710 24,095
Operating Margin 9.57% 9.74% 9.96% 13.5% 17.19% 17.89%
Earnings before Tax (EBT) 1 13,315 13,208 14,152 21,029 23,724 25,201
Net income 1 9,320 9,577 9,609 14,716 16,216 17,278
Net margin 7.23% 7.38% 7.2% 10.03% 12.28% 12.83%
EPS 2 306.2 314.7 316.5 486.7 536.2 571.2
Free Cash Flow 1 9,834 6,703 5,567 10,001 5,968 7,436
FCF margin 7.63% 5.17% 4.17% 6.81% 4.52% 5.52%
FCF Conversion (EBITDA) 49.68% 32.7% 26.14% 35.5% 18.81% 22.22%
FCF Conversion (Net income) 105.51% 69.99% 57.94% 67.96% 36.8% 43.04%
Dividend per Share 2 55.00 57.50 57.50 72.50 80.00 110.0
Announcement Date 6/28/18 6/27/19 6/26/20 6/29/21 6/29/22 6/29/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2021 S2 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3
Net sales 1 67,129 60,670 - 34,105 61,692 31,376 39,030 - 27,690 34,938 62,628 30,853 41,167 - 29,180 37,361 66,541 32,717
EBITDA - - - - - - - - - - - - - - - - - -
EBIT 1 7,159 6,978 - 6,185 10,380 5,483 6,845 - 4,033 7,037 11,070 5,007 8,016 - 5,101 8,850 13,951 5,335
Operating Margin 10.66% 11.5% - 18.14% 16.83% 17.48% 17.54% - 14.56% 20.14% 17.68% 16.23% 19.47% - 17.48% 23.69% 20.97% 16.31%
Earnings before Tax (EBT) 1 7,616 7,731 - 6,633 10,980 5,834 - - 4,428 - 11,792 5,085 - - 5,352 - 14,280 5,479
Net income 1 5,385 5,464 - 4,722 7,493 4,086 4,637 - 2,851 5,268 8,119 3,487 5,672 - 3,495 6,315 9,810 3,826
Net margin 8.02% 9.01% - 13.85% 12.15% 13.02% 11.88% - 10.3% 15.08% 12.96% 11.3% 13.78% - 11.98% 16.9% 14.74% 11.69%
EPS 2 177.0 180.7 - - 247.8 135.1 - - 94.27 - 268.4 115.3 - - 115.5 - 324.3 126.4
Dividend per Share 37.50 37.50 100.0 - 50.00 - - 102.5 - - 70.00 - - 100.0 - - 80.00 -
Announcement Date 10/31/19 10/30/20 5/14/21 10/29/21 10/29/21 1/31/22 5/13/22 5/13/22 7/29/22 10/31/22 10/31/22 1/31/23 5/15/23 5/15/23 7/31/23 10/31/23 10/31/23 1/31/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 43,799 42,942 45,159 54,052 60,732 64,788
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 9,834 6,703 5,567 10,001 5,968 7,436
ROE (net income / shareholders' equity) 8.5% 8.24% 7.89% 11.2% 11.3% 11%
ROA (Net income/ Total Assets) 5.08% 4.96% 5.04% 6.87% 7.33% 7.48%
Assets 1 183,472 192,956 190,783 214,222 221,216 230,854
Book Value Per Share 2 3,721 3,916 4,115 4,563 4,955 5,390
Cash Flow per Share 2 1,526 1,539 1,624 1,871 2,118 2,247
Capex 1 6,887 7,940 12,426 11,435 13,799 11,927
Capex / Sales 5.34% 6.12% 9.32% 7.79% 10.45% 8.86%
Announcement Date 6/28/18 6/27/19 6/26/20 6/29/21 6/29/22 6/29/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
FUKUDA DENSHI CO., LTD. Stock Fukuda Denshi Co., Ltd.
-9.36% 1.25B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.47% 218B
DANAHER CORPORATION Stock Danaher Corporation
+7.47% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+13.15% 134B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+25.74% 106B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-1.33% 61.12B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.89B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.56% 40.3B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+3.26% 35.53B
RESMED, INC. Stock ResMed, Inc.
+26.61% 32.05B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. 6960 Stock
  4. Financials Fukuda Denshi Co., Ltd.